Navigation Links
Air Force Office of Scientific Research hosts annual program Spring Review
Date:2/29/2012

The Air Force Office of Scientific Research will soon host its annual Spring Review from 5 through 9 March, 2012. This program review, to be held at 950 Glebe Road, Suite 210, in Arlington, Virginia, will be the 55th formally designated annual assessment of AFOSR's research portfolio.

Since its establishment in 1951, AFOSR has been responsible for investing in extramural basic research programs at leading universities and in-house (intramural) Air Force laboratories. During the first five years of AFOSR's existence, the annual budget was relatively lean (as was the staffbetween 20 to 27 personnel).

It was then that history intervened when the Soviet Union launched Sputnik, the first earth satellite, in October 1957. Almost overnight, AFOSR's budget almost doubled, and with it, a gradual commensurate boost in personnel. Sputnik was a major wake-up call regarding the overwhelming importance of science and technology to the future security, as well as economic vitality, of the United States. It was a hard lesson.

For several decades thereafter, AFOSR held not only a Spring Review, but a Fall Review as well. By 1975 AFOSR was responsible for all Air Force basic research funding, and the bi-annual reviews continued to provide a formal review of the status and areas of emphasis in the overall basic research portfolio.

Although AFOSR reverted to an annual review in the 1990's, this management tool continues to provide an excellent opportunity for both an introspective self-examination of a wide-ranging research portfolio as well as welcoming the views of customers and stakeholders in the continuous pursuit of cutting edge research that forges the foundation of our future Air Force.


'/>"/>

Contact: Robert White
robert.white@afosr.af.mil
703-588-0665
Air Force Office of Scientific Research
Source:Eurekalert

Page: 1

Related biology news :

1. Twisting molecules by brute force: A top-down approach
2. Wheat cant stop Hessian flies, so scientists find reinforcements
3. Law enforcement vital for great ape survival
4. New materials capability to increase weapons explosive force demonstrated at Navy test range
5. Human, artificial intelligence join forces to pinpoint fossil locations
6. Chemists reveal the force within you
7. Plants feel the force
8. American Well and Numera Join Forces to Integrate Home Monitoring and Telehealth Services
9. Hawaii, Arkansas and Oklahoma Lead the Nation for Methamphetamine Use in the Workforce, Reveals Quest Diagnostics Drug Testing Index™
10. Biologists discovery may force revision of biology textbooks
11. Climate change forces early spring
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/7/2017)... , February 7, 2017 Ipsidy ... Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") a ... transaction processing services, is pleased to announce the following ... Effective January 31, 2017, Philip D. ... Directors, CEO and President.  An experienced payment industry professional ...
(Date:2/2/2017)... NEW YORK , Feb. 2, 2017  EyeLock ... has released a new white paper " What You ... The problem of ensuring user authenticity is a ... protect the authentication of users. However, traditional authentication schemes ... Biometric authentication offers an elegant ...
(Date:1/26/2017)... CITY , Jan. 26, 2017  Crossmatch, a ... unveiled a new solution aimed at combatting fraud, waste ... solution was introduced at the Action on Disaster Relief ... key meeting point for UN agencies and foreign assistance ... Fraud, waste and abuse are a largely unacknowledged ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... ... ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, today announced ... for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ). The ... therapeutic levels of olanzapine for a period of 3 months., “We are honored and ...
(Date:2/24/2017)... , Feb. 24, 2017 Symic Bio, ... developing a new category of therapeutics, announced today the ... SB-030 in peripheral artery disease. The trial will evaluate ... single-use therapeutic, in the reduction of restenosis following angioplasty. ... critical development milestone for SB-030," said Nathan Bachtell ...
(Date:2/24/2017)... Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading ... financial results for the fourth quarter and fiscal year of ... Total sales in the fourth quarter of ... 13.6% in USD terms to $77.6 million from $68.3 million ... profit increased by 13.3% to $46.8 million from $41.3 million ...
(Date:2/23/2017)... 2017 ... share data, unaudited)Three Months Ended December 31,Twelve Months Ended ... $           ... 89026%Aldurazyme Net Product Revenue 3539(10)%9498(4)%Kuvan ... Product Revenue  756025%297303(2)%Vimizim Net Product ...
Breaking Biology Technology: